Novartis Pharma AG: Novartis Kisqali prolonged PFS benefit for pre- and perimenopausal patients with aggressive HR+/HER2- metastatic breast cancer compared to chemotherapy

RIGHT Choice Phase II trial is the first randomized study in patients with aggressive HR+/HER2- metastatic breast cancer (MBC), including visceral crisis, comparing a CDK4/6 inhibitor (CDK4/6i) plus endocrine

Related Keywords

United States ,Norway ,New Jersey ,San Antonio ,Texas ,Switzerland ,Spain ,East Hanover ,Barcelona ,Comunidad Autonoma De Cataluna ,America ,American ,Richard Jarvis ,Isabella Zinck ,Jeff Legos ,Yen Shen Lu ,Michael Meo ,Satoshi Sugimoto ,Nicole Zinsli Somm ,Samir Shah ,Parag Mahanti ,Julie Masow ,Sloan Simpson ,Mary Carmichael ,American Society Of Clinical Oncology ,European Society Of Medical Oncology ,Twitter ,Vestre Viken Hospital ,Translational Research In Oncology ,Novartis ,Novartis Pharmaceuticals ,Pfizer Inc ,National Taiwan University Hospital ,National Comprehensive Cancer Network ,Novartis Institutes For Biomedical Research ,Astex Pharmaceuticals ,European Commission ,Drug Administration ,Oncology At Department Of ,Exchange Commission ,Novartis Pharmaceuticals Corporation ,Akershus University Hospital ,Novartis Pharmaceuticals Corp ,European Society For Medical Oncology ,Breast Cancer Congress ,Antonio Breast Cancer Symposium ,Division Chief ,Medical Oncology ,National Taiwan University ,Executive Vice President ,Global Head ,Clinical Benefit Scale ,United States Food ,Novartis Institutes ,Biomedical Research ,Prescribing Information ,Advanced Breast ,European Society ,Breast Cancer ,Survival With Ribociclib Plus Letrozole ,Endocrine Therapy ,American Society ,Clinical Oncology ,Annual Meeting ,San Antonio Breast Cancer Symposium ,Practice Guidelines ,Published April ,Published March ,Translational Research ,Evaluate Efficacy ,Ribociclib With Endocrine Therapy ,Adjuvant Treatment ,Patients With ,Vestre Viken Hospital Trust ,Neoadjuvant Treatment ,Dharma ,Kisqali ,Bprolonged ,Benefit ,Perimenopausal ,Patients ,Aggressive ,Ther2 ,Metastatic ,Breast ,Dancer ,Ompared ,Chemotherapy ,